These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11870624)
1. Bag-1 up-regulation in anti-CD4 mAb treated allo-activated T cells confers resistance to apoptosis. Sawitzki B; Lehmann M; Vogt K; Risch K; Brock J; Kupiec-Weglinski JW; Volk HD Eur J Immunol; 2002 Mar; 32(3):800-9. PubMed ID: 11870624 [TBL] [Abstract][Full Text] [Related]
2. Bag-1 up-regulation in anti-CD4 mAb-treated allo-activated T cell confers resistance to activation-induced cell death (AICD). Sawitzki B; Lehmann M; Vogt K; Seifert M; Risch K; Brock J; Kupiec-Weglinski JW; Volk HD Transpl Immunol; 2002 May; 9(2-4):83-91. PubMed ID: 12180851 [TBL] [Abstract][Full Text] [Related]
3. Role of double-negative regulatory T cells in long-term cardiac xenograft survival. Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350 [TBL] [Abstract][Full Text] [Related]
4. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458 [TBL] [Abstract][Full Text] [Related]
5. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Arima T; Lehmann M; Flye MW Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332 [TBL] [Abstract][Full Text] [Related]
6. Abrogation of antibody-mediated allograft rejection by regulatory CD4 T cells with indirect allospecificity. Callaghan CJ; Rouhani FJ; Negus MC; Curry AJ; Bolton EM; Bradley JA; Pettigrew GJ J Immunol; 2007 Feb; 178(4):2221-8. PubMed ID: 17277127 [TBL] [Abstract][Full Text] [Related]
7. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K; Arima T; Yu S; Lehmann M; Flye MW Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640 [TBL] [Abstract][Full Text] [Related]
8. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374 [TBL] [Abstract][Full Text] [Related]
9. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4. Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484 [TBL] [Abstract][Full Text] [Related]
11. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice. Song HK; Alters SE; Fathman CG Transplantation; 1993 Jan; 55(1):133-9. PubMed ID: 8420037 [TBL] [Abstract][Full Text] [Related]
12. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837 [TBL] [Abstract][Full Text] [Related]
13. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489 [TBL] [Abstract][Full Text] [Related]
14. Fas ligand gene transfer prolongs rat renal allograft survival and down-regulates anti-apoptotic Bag-1 in parallel with enhanced Th2-type cytokine expression. Ke B; Coito AJ; Kato H; Zhai Y; Wang T; Sawitzki B; Seu P; Busuttil RW; Kupiec-Weglinski JW Transplantation; 2000 Apr; 69(8):1690-4. PubMed ID: 10836382 [TBL] [Abstract][Full Text] [Related]
15. Regulation of programmed cell death following T cell activation in vivo. Yang Y; Kim D; Fathman CG Int Immunol; 1998 Feb; 10(2):175-83. PubMed ID: 9533445 [TBL] [Abstract][Full Text] [Related]
16. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Motoyama K; Arima T; Lehmann M; Flye MW Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125 [TBL] [Abstract][Full Text] [Related]
17. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872 [TBL] [Abstract][Full Text] [Related]
18. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213 [TBL] [Abstract][Full Text] [Related]
19. Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody. Pearson TC; Madsen JC; Larsen CP; Morris PJ; Wood KJ Transplantation; 1992 Sep; 54(3):475-83. PubMed ID: 1384183 [TBL] [Abstract][Full Text] [Related]
20. Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts. Tung TC; Oshima K; Cui G; Laks H; Sen L Am J Physiol Heart Circ Physiol; 2003 Sep; 285(3):H964-73. PubMed ID: 12915385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]